Disclosure Of Transactions In On Shares From September 29Th To October 03Rd,2025

2025-10-08 11:46:50

(MENAFN- GlobeNewsWire - Nasdaq) Nanterre, October 06th, 2025

Disclosure of transactions in on shares

from September 29 ^th to October 03 ^rd ,2025

Within the framework of the authorization granted by the General Meeting of VINCI SA of April 17^th, 2025, to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from September 29^th to October 03^rd,2025:

I - Aggregate presentation by day and by market

Issuer's name	Date of transaction	Identifying code of financial instrument	Aggregated daily volume (in number of shares)	Daily weighted average price of the purchased shares in Euro	Market (MIC code)
VINCI	29/09/2025	FR0000125486	100 000	116,461084	XPAR
VINCI	30/09/2025	FR0000125486	100 000	117,197862	XPAR
VINCI	01/10/2025	FR0000125486	100 000	118,028409	XPAR
VINCI	02/10/2025	FR0000125486	77 132	117,936600	XPAR
VINCI	02/10/2025	FR0000125486	36 804	118,276400	CEUX
VINCI	02/10/2025	FR0000125486	5 995	118,300300	TQEX
VINCI	03/10/2025	FR0000125486	75 442	117,895100	XPAR
VINCI	03/10/2025	FR0000125486	35 601	118,807700	CEUX
VINCI	03/10/2025	FR0000125486	5 905	118,691400	TQEX

		TOTAL	536 879	117,6289

II - Details of transactions

In accordance with Article 5 (1) (b) of Regulation (EU) No 596/2014 (Regulation on market abuse), detailed information is available on the VINCI website:

______________________

Attachment

Communique VINCI - declaration hebdo- rachat d'actions from to 29-09-25 to 03-10-25 vGB

MENAFN08102025004107003653ID1110168437

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.